Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Effect of Manager Forecast of Future Sales on Company Risk During Sales Decline Using the Fama-French Five-Factor ModelIranian journal of management studies, 2021-06, Vol.14 (3), p.509-525 [Peer Reviewed Journal]COPYRIGHT 2021 University of Tehran, Farabi College ;2021. This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2008-7055 ;EISSN: 2345-3745 ;DOI: 10.22059/IJMS.2021.296411.673936Full text available |
|
2 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS38.90) loses NIS689 million ($180 million) (1.6%) in MCap, steepest heavyweight fall in TA-25 IndexCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 27, 2023Digital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS39.52) loses NIS866 million ($227 million) (1.9%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research SectorCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 26, 2023Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS40.30) strengthens above moving average priceCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 20, 2023Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS40.59) hits year-high 3rd time in three monthsCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 18, 2023Digital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS40.30) in top 1% performers of TA-25 Index, hits thirty-two-month highCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 14, 2023Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS36.81) increases 0.5% against the trendCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 4, 2023Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS36.62) loses NIS422 million ($111 million) (1.0%) in MCap, steepest heavyweight fall in TA-25 IndexCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 3, 2023Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS37.0) adds NIS489 million ($129 million) (1.2%) in MCap, top heavyweight rise in Pharmaceuticals Medical Research SectorCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 31, 2023Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS37.37) rises in 4 out of last 5 days; 5-day rise of 4.4Company Data Report, 2023Copyright News Bites Pty Ltd Aug 24, 2023Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS40.30) outperforming 98% of stocks, reports 5.9% sequential rise in Quarterly RevenueCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 21, 2023Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Checkpoint Therapeutics (CKPT: $1.97) drops 1.5%; -3c [-1.5%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Sep 12, 2023Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Checkpoint Therapeutics (CKPT: $2.0) climbs 2.6%; +5c [2.6%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Sep 11, 2023Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS36.18) drops 1.3%, 4 days' volume in a dayCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 6, 2023Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS36.65) decreases on spectacular volumeCompany Data Report, 2023Copyright News Bites Pty Ltd Sep 5, 2023Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS36.10) loses NIS1 billion ($371 million) (3.4%) in MCap, steepest heavyweight fall in TA-25 IndexCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 27, 2023Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS37.03) loses NIS566 million ($150 million) (1.4%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research SectorCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 23, 2023Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS35.77) hits five-month high on strong volumeCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 7, 2023Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS34.28) falls 0.8% from 14-day highCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 3, 2023Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Teva Pharmaceutical Industries (TEVA: NIS34.57) in top 1% performers of TA-25 Index, hits 111-day highCompany Data Report, 2023Copyright News Bites Pty Ltd Aug 2, 2023Digital Resources/Online E-Resources |